NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
168 hedge funds and large institutions have $1.62B invested in NxStage Medical Inc. in 2017 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 55 closing their positions.
1,099% more call options, than puts
Call options by funds: $29.7M | Put options by funds: $2.47M
11% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 55
3% more funds holding
Funds holding: 163 → 168 (+5)
5% more capital invested
Capital invested by funds: $1.55B → $1.62B (+$71.3M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
24% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$106M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$82.1M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$78.4M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$57.7M |
| 5 |
JP Morgan Chase
New York
|
+$49.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$249M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$64.5M |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$60.7M |
| 4 |
DM
Deerfield Management
New York
|
-$60.1M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$49.1M |
NXTM Hedge Fund Activity: Q3 2017 in Review
168 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2017, worth a combined $1.62B — up 4.6% from $1.55B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new NXTM positions and 55 closed out — a net gain of 6 holders — while 39 added to existing stakes and 51 trimmed.
The largest buyer was Alpine Associates Management, opening a new position worth an estimated $106M. The largest seller was Fidelity Investments, cutting an estimated $249M.
- 168 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2017, up from 163 in Q2 2017.
- Funds reported $1.62B of NxStage Medical Inc. stock for Q3 2017, up 4.6% quarter-over-quarter.
- 61 funds opened new NxStage Medical Inc. positions in Q3 2017 and 55 closed out, a net change of +6 holders.
- The largest NxStage Medical Inc. buyer in Q3 2017 was Alpine Associates Management, an estimated $106M added.
- The largest NxStage Medical Inc. seller in Q3 2017 was Fidelity Investments, an estimated $249M sold.
Based on aggregated 13F filings for Q3 2017.